Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
This marks the first partnership between Pfizer and Cipla in India
Subscribe To Our Newsletter & Stay Updated
